Skip to main content

Advertisement

Table 2 Response to GD by histological subtypes

From: Feasibility and efficacy of gemcitabine and docetaxel combination chemotherapy for bone and soft tissue sarcomas: multi-institutional retrospective analysis of 134 patients

  CR PR SD PD NE RR (%)
All 2 11 55 55 11 9.7
Leiomyosarcoma 0 5 19 12 2 13.2
Undifferentiated pleomorphic sarcoma 1 2 11 4 2 15.0
Osteosarcoma 0 0 7 8 2 0
Liposarcoma 0 0 2 5 2 0
Synovial sarcoma 0 0 3 4 0 0
Malignant peripheral nerve sheath tumor 0 1 0 5 1 14.3
Angiosarcoma 0 1 1 1 1 25.0
Ewing sarcoma 0 1 1 2 0 25.0
Epithelioid sarcoma 0 0 1 3 0 0
Rhabdomyosarcoma 0 0 2 1 0 0
Others 1 1 8 10 1 9.5
  1. CR complete response, PR partial response, SD stable disease, PD progressive disease, NE not evaluable, RR response rate